POZ - Latino Hub : Treatment News

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » News & Views » Treatment News


 
July 29, 2010
Prevention Is Failing to Target MSM When They’re Young Enough
July 28, 2010
Global Survey: Stigma, Isolation and Discrimination Still Pervasive
Universal HIV Treatment Access No Guarantee of Health for Socially Disadvantaged
July 27, 2010
OM-85 BV: A Bacterial Vaccine Against Respiratory Problems in People with HIV and COPD?
Low Vitamin D Levels Not Associated With HIV Drugs
July 26, 2010
HPV Cancer Vaccine Effective for Heterosexual, Gay and Bisexual Men
Tibotec Submits Approval Application for HIV Non-Nuke Rilpivirine
Study Finds PrEP Is Safe in Gay and Bi Men
July 23, 2010
Longer Duration of HIV Infection Might Increase the Risk of Brain Disorders
Circumcision Unlikely to Have Major HIV Prevention Benefit Among Gay Men
More Details of TBR-652’s Antiviral and Anti-Inflammatory Potential Reported
Nearly 75 Percent of People With HIV Might Have Bone Problems
July 22, 2010
ViiV HIV Integrase Inhibitor Performing Well in First-Time Treatment Study
Reyataz/Isentress Combo Spares Norvir and Nukes, But Is Integrase Resistance a Concern?
Health Care Providers and People With HIV Not Communicating Effectively
Rilpivirine Has Similar Efficacy and Better Tolerability Than Sustiva
Extended-Release Viramune Has Comparable Safety and Efficacy to Standard Viramune
Possibly No Survival Benefit to Starting HIV Treatment at CD4s of 500 or More
Once-Daily Prezista/Norvir Monotherapy Largely Effective Over 96 Weeks
Abacavir/Lamivudine Equivalent to Tenofovir/Emtricitabine in Canadian Cohort Study
July 21, 2010
Microbicide Success Story: What It Means and Where We Go Next
Non-AIDS Cancers Occurring at Earlier Age Among People With HIV
Hep C Treatment Effective in HIV Patients With Normal Liver Enzymes
MACS: Childhood Sex Abuse and Victimization Linked to Increased HIV Risk
Full-Scale HIV Treatment and Prevention Could Save Millions of Lives
Aging Might Have a Smaller Impact on Immune Function Than Suspected
July 20, 2010
Tenofovir Microbicidal Gel Significantly Cuts HIV Infection Rate
5.2 Million People With HIV in Low- and Middle-Income Countries Now on Treatment
At Least 31 Countries Deporting People Living With HIV
Viramune Boosts Hep C Treatment Efficacy in People With HIV
HIV/HCV Coinfection Further Increases Risk of Bone Fractures
New ViiV Integrase Inhibitor Effective Against Some Isentress-Resistant HIV Strains
HIV Cases in Young People Are Falling Around the World
Fewer Malignancies Seen in Those Taking Selzentry
July 19, 2010
Strategies for a Cure Reviewed in Vienna
Kaletra/Isentress Shows Promise as HIV Nuceleoside-Sparing Regimen for First-Line Treatment
Switch From Sustiva to Intelence Reduces Central Nervous System Side Effects
Argos’s Dendritic Cell Therapy Reduces HIV During Treatment Interruption
Protease Inhibitor-to-Isentress Switch is Effective, Lipid Friendly
Preliminary Results Suggest Good Safety and Adherence Profile for PrEP
July 16, 2010
Earlier Treatment Cuts Risk of Death by 75 Percent in Haitian Study
July 15, 2010
Merck Terminates Development of Its HIV Entry Inhibitor, Vicriviroc
July 14, 2010
Activist Group Claims HIV Cure Is Closer Than Many Think
July 09, 2010
Newly Discovered Antibody Kills Up to 91 Percent of HIV Strains
July 08, 2010
Increased Mortality Seen in Women With Kidney Disease Despite HIV Treatment
July 07, 2010
HIV Stem Cell Therapy in Mice Is Successful
July 06, 2010
Boosting Dose of Norvir Doesn’t Affect Insulin
July 02, 2010
Atripla Co-pay Program to Cover More People
July 01, 2010
HIV-Positive People on Abacavir Don’t Have More Inflammation

 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
 
Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.